Intangible Assets: Amortization, Goodwill, and Impairment Journal Entries

US GAAP divides intangibles into three categories with distinct accounting: 1. Definite-lived intangibles (e.g., patents, copyrights, customer lists with finite life). Amortized over their useful life — typically straight-line. Tested for impairment only when a triggering event suggests recoverability is at risk (recoverability test under ASC 360). 2. Indefinite-lived intangibles (e.g., trademarks with perpetual renewal, broadcast licenses). NOT amortized. Tested for impairment annually under ASC 350, regardless of triggering events. 3. Goodwill (arises only from business combinations). NOT amortized. Tested for impairment annually at the reporting unit level under ASC 350. Special rules apply. Internally developed intangibles (except some capitalized software costs under ASC 985-20 and ASC 350-40) are generally expensed as R&D rather than capitalized — this is a major GAAP/IFRS difference. Under IFRS, internally developed intangibles can be capitalized once criteria are met. Under US GAAP, most are expensed. The asset category determines EVERYTHING about subsequent accounting. Misclassify a customer list as indefinite-lived and you'll under-expense it for years. Misclassify a trademark as definite-lived and you'll over-expense it. The useful life determination happens at acquisition and is reviewed each period — but changes require special handling under ASC 250 (a change in accounting estimate).

Acme Corp acquires a patent from another company on January 1, 20X1, for $480,000. The remaining legal life is 15 years, and management estimates the economic useful life at 10 years (after which competitors will likely have developed workaround technology). No residual value. Acquisition entry: Dr. Patent .......................... 480,000 Cr. Cash ......................... 480,000 Amortization uses the shorter of legal life or economic useful life — here, 10 years. Annual amortization = $480,000 / 10 = $48,000. Year 1 amortization entry (December 31, 20X1): Dr. Amortization Expense .......... 48,000 Cr. Accumulated Amortization – Patent ...................... 48,000 The Accumulated Amortization account parallels Accumulated Depreciation on tangible assets — it reduces the carrying value of the patent over time. After Year 5: Carrying value = $480,000 – (5 × $48,000) = $480,000 – $240,000 = $240,000. Alternative: some companies credit the Patent account directly instead of using an Accumulated Amortization contra-account. Both presentations are acceptable under GAAP; the contra-account method is more common because it preserves the original cost for disclosure. Legal fees to defend a patent are capitalized if defense is successful (increasing the patent's carrying value), expensed if unsuccessful. Example: Acme spends $30,000 on a successful infringement lawsuit in Year 3. Dr. Patent .......................... 30,000 Cr. Cash .......................... 30,000 Amortization going forward is based on the new carrying value over the remaining useful life: Carrying value at start of Year 4 = ($480,000 – 3 × $48,000) + $30,000 = $336,000 + $30,000 = $366,000. Remaining useful life = 7 years. New annual amortization = $366,000 / 7 = $52,285.71. The revised amortization is a change in accounting estimate under ASC 250 — applied prospectively, no restatement of prior periods.

The impairment test DIFFERS by category. Definite-lived intangibles (ASC 360): TWO-STEP recoverability test triggered when events suggest the asset may be impaired (e.g., adverse legal ruling, loss of key customer, significant decline in market conditions). Step 1 — Recoverability test: Compare carrying value to sum of UNDISCOUNTED future cash flows expected from the asset. If carrying value > undiscounted cash flows, proceed to Step 2. Step 2 — Measurement: Impairment loss = Carrying value – Fair value. Fair value is typically measured using DCF (discounted cash flows). Worked example: Acme's patent has a carrying value of $240,000 at the end of Year 5. A competitor releases alternative technology, reducing expected cash flows. Step 1 — Undiscounted expected future cash flows = $200,000. Since carrying value ($240,000) > undiscounted cash flows ($200,000), impairment is indicated. Step 2 — Fair value (DCF at 8%) = $170,000. Impairment loss = $240,000 – $170,000 = $70,000. Impairment entry: Dr. Loss on Impairment – Patent ... 70,000 Cr. Accumulated Amortization – Patent ...................... 70,000 (or Cr. Patent directly) Carrying value after impairment = $170,000. Future amortization is calculated on the new carrying value over the remaining useful life (5 years). New annual amortization = $170,000 / 5 = $34,000. Important: impairment losses on definite-lived intangibles are NOT reversible under US GAAP even if circumstances later improve. (IFRS allows reversal.) Indefinite-lived intangibles (ASC 350): SINGLE-STEP test performed annually OR qualitatively first. Option 1 — Qualitative assessment: Management evaluates whether it is "more likely than not" (probability > 50%) that the asset is impaired. If yes, proceed to quantitative test. Option 2 — Quantitative test: Compare fair value to carrying value. If fair value < carrying value, impairment = carrying value – fair value. Worked example: Acme has a trademark with carrying value $300,000 (indefinite-lived). Annual impairment test shows fair value = $250,000. Impairment loss = $300,000 – $250,000 = $50,000. Dr. Loss on Impairment – Trademark ... 50,000 Cr. Trademark ...................... 50,000 No recoverability test for indefinite-lived — just direct comparison of fair value to carrying value. Impairment losses are NOT reversible.

Goodwill arises only in business combinations. It represents the excess of purchase price over the fair value of identifiable net assets acquired. Worked example: On January 1, 20X1, Acme acquires TargetCo for $10,000,000 in cash. Fair value of TargetCo's identifiable assets = $12,000,000. Fair value of liabilities assumed = $3,500,000. Therefore, net identifiable assets = $8,500,000. Goodwill = Purchase price – Net identifiable assets = $10,000,000 – $8,500,000 = $1,500,000. Acquisition entry: Dr. Various identifiable assets .... 12,000,000 Dr. Goodwill ....................... 1,500,000 Cr. Various liabilities ........ 3,500,000 Cr. Cash ....................... 10,000,000 Goodwill is NOT amortized. It is tested for impairment annually at the REPORTING UNIT LEVEL (not at the individual asset level). A reporting unit is an operating segment or one level below — not the entire company. Impairment test for goodwill under ASC 350 (after 2017 simplification): Step 1 — Qualitative assessment (optional): Is it more likely than not that the reporting unit's fair value is less than its carrying value? If no, skip Step 2. Step 2 — Quantitative test: Compare fair value of reporting unit to its carrying value (including goodwill). If carrying value > fair value, impairment = carrying value – fair value. Impairment loss is limited to the amount of goodwill allocated to that reporting unit. Worked example: Acme has a reporting unit (Division A) with carrying value $10,000,000 (including $1,500,000 goodwill). Fair value at year-end = $9,200,000. Impairment indicated = $10,000,000 – $9,200,000 = $800,000. Impairment loss = MIN($800,000, $1,500,000 goodwill) = $800,000. Dr. Loss on Impairment – Goodwill ... 800,000 Cr. Goodwill ...................... 800,000 Remaining goodwill on the books = $1,500,000 – $800,000 = $700,000. Goodwill impairment losses are NOT reversible, even if the reporting unit's fair value later recovers. This is a permanent impairment that reduces retained earnings permanently. Private company alternative: Under ASC 350-20, private companies may elect to AMORTIZE goodwill straight-line over 10 years (or less if justified) instead of annual impairment testing. This reduces cost and complexity but produces different financial statements than public companies using the impairment-only model.

A customer list acquired in a business combination typically has a definite useful life — representing the expected future revenue from existing customer relationships over some period. Worked example: As part of acquiring TargetCo (above), Acme identifies a customer list with fair value $400,000 and estimated useful life 8 years. Acquisition entry (as part of the business combination): Dr. Customer List ............... 400,000 (allocated from Goodwill or additional PPA) Straight-line amortization: Annual amortization = $400,000 / 8 = $50,000. Year 1: Dr. Amortization Expense ..... 50,000 Cr. Accumulated Amortization – Customer List ........ 50,000 Alternative methods: some customer lists decay at varying rates — more revenue from the list in early years, less in later. Accelerated amortization (sum-of-years'-digits or pattern-based) is acceptable if it better reflects the pattern of economic consumption. Brands and trademarks: some indefinite-lived, some definite-lived. Indefinite-lived if the trademark can be renewed indefinitely at nominal cost and continues to generate revenue without maintenance beyond renewal fees. Definite-lived if the trademark is tied to a product with a finite economic life. Computer software: - Purchased software: capitalized and amortized over useful life. - Internally developed software for internal use (ASC 350-40): preliminary project costs expensed; application development costs capitalized. - Software to be sold (ASC 985-20): research costs expensed; development costs after technological feasibility capitalized. Licenses, franchises, broadcast rights: typically definite-lived, amortized over the license period. Non-compete agreements: always definite-lived, amortized over the non-compete period (usually 2-5 years). Preparing for audit: intangible assets require detailed disclosure schedules showing gross cost, accumulated amortization, net carrying value, useful life assumed, amortization method, and impairment losses by period. Auditors will sample intangibles and challenge useful life estimates, especially for customer lists and trademarks. Document the basis for useful life estimates carefully.

Mistake 1 — Amortizing indefinite-lived intangibles. A trademark with indefinite life should NOT be amortized. If you record annual amortization expense on it, you're overstating expenses and understating the asset. Reclassify immediately. Mistake 2 — Amortizing goodwill (public company). Goodwill is never amortized for public companies. Private companies may elect to amortize under ASC 350-20, but the default is impairment testing only. Mistake 3 — Using undiscounted cash flows for impairment MEASUREMENT. Undiscounted cash flows are only used in Step 1 of the definite-lived intangible test (recoverability). If Step 1 indicates impairment, measurement in Step 2 uses fair value (discounted cash flows). Mistake 4 — Reversing an impairment loss. Under US GAAP, impairment losses are PERMANENT. Even if circumstances later improve, you cannot write the asset back up. (IFRS allows reversal of some impairments — know the difference.) Mistake 5 — Testing goodwill at the wrong level. Goodwill is tested at the reporting unit level, not at the individual asset level or at the consolidated entity level. Misidentifying reporting units leads to incorrect impairment conclusions. Mistake 6 — Capitalizing R&D as an intangible. US GAAP generally expenses R&D. Only specific categorized costs (capitalizable software, acquired in a business combination) can be capitalized. Capitalizing general R&D overstates assets. Mistake 7 — Treating legal defense costs uniformly. Successful defense = capitalize. Unsuccessful defense = expense immediately. The outcome, not the activity, determines treatment. Mistake 8 — Ignoring the useful life review. Useful life assumptions must be reviewed each reporting period. A customer list estimated at 8 years might need revision if customer attrition is faster than expected. Changes are prospective. Mistake 9 — Misclassifying a change in accounting principle vs a change in estimate. Changing amortization METHOD (e.g., straight-line to accelerated) is a change in principle — requires retrospective application. Changing USEFUL LIFE is a change in estimate — prospective only. Mistake 10 — Forgetting that impairment losses are below-the-line for financial analysts. Analysts often exclude impairment losses from "normalized" earnings to focus on ongoing operations. This doesn't mean you don't book the loss — you do — but be aware of how it's interpreted in analysis.